Literature DB >> 22301850

Accessory molecules for Toll-like receptors and their function.

Clarissa C Lee1, Ana M Avalos, Hidde L Ploegh.   

Abstract

Toll-like receptors (TLRs) are essential components of the innate immune system. Accessory proteins are required for the biosynthesis and activation of TLRs. Here, we summarize recent findings on TLR accessory proteins that are required for cell-surface and endosomal TLR function, and we classify these proteins based on their function as ligand-recognition and delivery cofactors, chaperones and trafficking proteins. Because of their essential roles in TLR function, targeting of such accessory proteins may benefit strategies aimed at manipulating TLR activation for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301850      PMCID: PMC3677579          DOI: 10.1038/nri3151

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  103 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails.

Authors:  N Tao; S J Wagner; D M Lublin
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

Review 3.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

4.  A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors.

Authors:  Takashi Kiyokawa; Sachiko Akashi-Takamura; Takuma Shibata; Fumi Matsumoto; Chiaki Nishitani; Yoshio Kuroki; Yasuyuki Seto; Kensuke Miyake
Journal:  Int Immunol       Date:  2008-09-09       Impact factor: 4.823

5.  Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.

Authors:  Ana M Avalos; Eicke Latz; Betty Mousseau; Sean R Christensen; Mark J Shlomchik; Frances Lund; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

6.  Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.

Authors:  Boyoun Park; Melanie M Brinkmann; Eric Spooner; Clarissa C Lee; You-Me Kim; Hidde L Ploegh
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

7.  Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Authors:  Hyun-Ku Lee; Stefan Dunzendorfer; Katrin Soldau; Peter S Tobias
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion.

Authors:  Sherry Wanderling; Birgitte B Simen; Olga Ostrovsky; Noreen T Ahmed; Shawn M Vogen; Tali Gidalevitz; Yair Argon
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

9.  RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.

Authors:  Antje Blumenthal; Toshihiko Kobayashi; Lynda M Pierini; Niaz Banaei; Joel D Ernst; Kensuke Miyake; Sabine Ehrt
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023

10.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Authors:  Sarah E Ewald; Alex Engel; Jiyoun Lee; Miqi Wang; Matthew Bogyo; Gregory M Barton
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

View more
  160 in total

1.  Systematic analysis of immunodeficiency.

Authors:  David F Tough
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

2.  Cloudy peritoneal dialysate: in search of a clear cause?

Authors:  Marien W J A Fieren
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

3.  The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.

Authors:  Kjetil H Egge; Andreas Barratt-Due; Stig Nymo; Julie K Lindstad; Anne Pharo; Corinna Lau; Terje Espevik; Ebbe B Thorgersen; Tom E Mollnes
Journal:  Clin Exp Immunol       Date:  2015-07-19       Impact factor: 4.330

4.  Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors:  Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

5.  miR-15a/16 regulates macrophage phagocytosis after bacterial infection.

Authors:  Hyung-Geun Moon; Jincheng Yang; Yijie Zheng; Yang Jin
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

6.  Identification and functional characterization of nonmammalian Toll-like receptor 20.

Authors:  Danilo Pietretti; Marleen Scheer; Inge R Fink; Nico Taverne; Huub F J Savelkoul; Herman P Spaink; Maria Forlenza; Geert F Wiegertjes
Journal:  Immunogenetics       Date:  2013-12-11       Impact factor: 2.846

7.  Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish.

Authors:  Da-Wei Yeh; Yi-Ling Liu; Yin-Chiu Lo; Chiou-Hwa Yuh; Guann-Yi Yu; Jeng-Fan Lo; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

Review 8.  Trafficking of endosomal Toll-like receptors.

Authors:  Bettina L Lee; Gregory M Barton
Journal:  Trends Cell Biol       Date:  2014-01-15       Impact factor: 20.808

Review 9.  Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes.

Authors:  Julien Moretti; J Magarian Blander
Journal:  Curr Opin Immunol       Date:  2013-12-05       Impact factor: 7.486

10.  Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice.

Authors:  Ana M Avalos; Oktay Kirak; J Margit Oelkers; Marina C Pils; You-Me Kim; Matthias Ottinger; Rudolf Jaenisch; Hidde L Ploegh; Melanie M Brinkmann
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.